Searched for
GENMAB
Drugmakers turn to AI to speed trials, regulatory submissionsAI is helping find participants and sites for clinical trials and drafting documents for regulators, shaving weeks off these labor-intensi...- U.S. stock futures rise today as Dow Jones, S&P 500 and Nasdaq rally ahead of jobs data with Nvidia, Oracle, Intel among top stocks to watchU.S. stock market futures rose Monday morning as investors aimed to bounce back from last week’s losses. Futures tied to the Dow Jones, S&P...
- Genmab to buy Dutch cancer drugmaker Merus for $8 billionDenmark's Genmab has agreed to acquire Dutch biotech Merus NV for $8 billion in cash, adding the head-and-neck cancer drug petosemtamab to ...
- Genmab inks $1.1 bn deal with Johnson & JohnsonDanish pharma firm Genmab has said that it had reached a deal worth up to $1.1 bn with US drug giant Johnson & Johnson.
Load More- Genmab inks $1.1 bn deal with Johnson & Johnson